WASHINGTON - Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's ...

Pfizer said Tuesday morning that final trial studies still show its experimental COVID-19 pill significantly reduced the risk of hospitalization or death linked to the virus, by 89%. The company also ...

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

GENEVA (AP) - Nearly three dozen companies worldwide will soon start making generic versions of Pfizer's coronavirus pill, the U.N.-backed Medicines Patent Pool that negotiated the deal said Thursday.

Pfizer announced Tuesday that it had entered an agreement with the UN that will expand access of its new COVID-19 antiviral pill to millions of people in poorer countries upon its approval. In a press ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...